These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6123930)

  • 21. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical modulation of striatal function.
    Scatton B; Worms P; Lloyd KG; Bartholini G
    Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T; Itahashi Y; Nomura Y
    J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors.
    Billet F; Dourmap N; Costentin J
    Eur J Neurosci; 2004 Nov; 20(10):2629-38. PubMed ID: 15548206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperresponsiveness to the inhibitory action of dopamine agonists on luteinizing hormone secretion in the monosodium-L-glutamate-treated, orchidectomized rat.
    Rose PA; Weick RF
    Neuroendocrinology; 1986; 44(1):95-101. PubMed ID: 3024058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
    Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
    Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico--striatal terminals in vitro.
    Rowlands GF; Roberts PJ
    Eur J Pharmacol; 1980 Mar; 62(2-3):241-2. PubMed ID: 7379845
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes.
    Lonart G; Johnson KM
    J Neurochem; 1994 Dec; 63(6):2108-17. PubMed ID: 7964730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
    J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK; Robertson RG
    Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms.
    Mercuri N; Bernardi G; Calabresi P; Cotugno A; Levi G; Stanzione P
    Brain Res; 1985 Dec; 358(1-2):110-21. PubMed ID: 2866815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors.
    Sokoloff P; Martres MP; Schwartz JC
    Nature; 1980 Nov; 288(5788):283-6. PubMed ID: 7432527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.